Volta

Challenges and Advances in the Simulation of Targeted Covalent Inhibitors Using Quantum Computing

Unknown authors · 2025
hash_id: 8ecc571c48573e0872700cfa8ee5f4a41fc8c3b41eee7f1d5fd32b8339261d41 · DOI: 10.1021/acs.jpclett.5c01680

High Resolution Image Download MS PowerPoint Slide Targeted covalent inhibitors represent a promising class of drugs that form specific chemical bonds with their biological targets. There are a multitude of molecular systems where covalent inhibitors could address human health challenges. A high-level quantum chemical description of the formation of the critical covalent bond could provide new mechanistic detail and insights into how the mechanism is influenced by the surrounding biomolecular environment. However, accurately simulating the reactivity and binding specificity of such inhibitors remains a significant challenge. By leveraging advances in quantum computing hardware and algorithms, we discuss how quantum computing could benefit the design of targeted covalent inhibitors and enable more accurate simulations of protein–ligand interactions and accelerate de novo …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (3)

Quantum computing for biotechnological innovation: transformative potential in … secondary
Small Molecule Drug Discovery Enhanced by Quantum AI secondary
Toward targeted covalent inhibition of Cruzipain for the treatment of Chagas di… secondary

Cited by (1)

Can quantum computing crack the biggest challenges in health? primary